Table 3.
Comparisons of OMA diameters at baseline (TB) and after 12 months (T12), in dienogest (D), estrogen-progestogens (EPs), and no-treatment (NoT) groups.
| D (n = 62) | EPs (n = 38) | NoT (n = 42) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| TB | T12 | p-Value | TB | T12 | p-Value | TB | T12 | p-Value | |
| Mean OMA diameter | 35.1 (12.5) | 25.8 (15.2) | <0.01 | 28.4 (8.7) | 16.7 (2.5) | <0.01 | 31.1 (13.7) | 33.8 (14.5) | <0.01 |
| Median OMA diameter | 35 (23–44) | 28 (14–39) | <0.01 | 30 (22–37) | 20 (13–30) | <0.01 | 31 (20–44) | 32.5 (21–44) | <0.01 |
| Bilateral OMAs | 28 (45.2%) | 14 (22.6%) | 0.03 | 10 (27%) | 4 (10.8%) | 0.30 | 9 (21.4%) | 9 (21.4%) | - |
TB: diameters at baseline; BMI: body mass index; OMA: ovarian endometrioma(s).
Data are expressed as mean (standard deviation), or median (interquartile range) or n (rate); mean and median OMA are expressed in millimeters.